BIANCHI, LUCIANO
 Distribuzione geografica
Continente #
NA - Nord America 412
EU - Europa 315
AS - Asia 88
SA - Sud America 19
AF - Africa 12
Totale 846
Nazione #
US - Stati Uniti d'America 410
DE - Germania 87
FI - Finlandia 49
IT - Italia 40
IE - Irlanda 34
RU - Federazione Russa 33
SE - Svezia 33
SG - Singapore 30
HK - Hong Kong 28
CN - Cina 21
BR - Brasile 17
UA - Ucraina 13
GB - Regno Unito 9
CI - Costa d'Avorio 8
FR - Francia 5
IN - India 5
BE - Belgio 3
MA - Marocco 3
CZ - Repubblica Ceca 2
DK - Danimarca 2
AT - Austria 1
CA - Canada 1
CL - Cile 1
CO - Colombia 1
EG - Egitto 1
ES - Italia 1
KR - Corea 1
MX - Messico 1
NO - Norvegia 1
PT - Portogallo 1
RO - Romania 1
SY - Repubblica araba siriana 1
TR - Turchia 1
VN - Vietnam 1
Totale 846
Città #
Munich 82
Chandler 80
Ashburn 43
Helsinki 43
Des Moines 39
Dublin 34
Hong Kong 28
Boardman 25
Fairfield 20
Singapore 15
Jacksonville 14
Turin 13
New York 12
Wilmington 12
Lawrence 10
Princeton 10
The Dalles 9
Abidjan 8
San Diego 8
San Mateo 8
Seattle 8
Washington 8
Woodbridge 7
Moscow 6
Ann Arbor 5
Milan 5
Pune 5
Ascoli Piceno 4
Centro 4
Jyväskylä 4
London 4
Los Angeles 4
Cambridge 3
Guangzhou 3
Houston 3
Shenzhen 3
Brussels 2
Chicago 2
Chiswick 2
Dallas 2
Fayetteville 2
Matera 2
Redmond 2
Rome 2
Shanghai 2
Verona 2
Wuhan 2
Aracruz 1
Barra Mansa 1
Beijing 1
Belém 1
Boydton 1
Bucaramanga 1
Cairo 1
Cajamar 1
Campinas 1
Centro Municipality 1
Contagem 1
Duartina 1
Farroupilha 1
Frankfurt am Main 1
Grandes Rios 1
Guararema 1
Hanoi 1
Hasselt 1
Izmir 1
Jiaxing 1
Joinville 1
Juiz de Fora 1
Kharkiv 1
Kilburn 1
Olomouc 1
Oslo 1
Ottawa 1
Piracicaba 1
Santiago 1
Stockholm 1
São José dos Quatro Marcos 1
São João da Boa Vista 1
São Paulo 1
Taiyuan 1
Tatuí 1
Ternopil 1
Tolentino 1
Weitang 1
Yiwu 1
Totale 650
Nome #
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: SUPREME study 173
Certolizumab for the treatment of psoriasis and psoriatic arthritis: a real-world multicentre Italian study 87
Creation of a severity index for hidradenitis suppurativa that includes a validated quality-of-life measure: the HIDRAscore 83
Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasis 80
Effects of a cream containing 5% hyaluronic acid mixed with a bacterial-wall-derived glycoprotein, glycyrretinic acid, piroctone olamine and climbazole on signs, symptoms and skin bacterial microbiota in subjects with seborrheic dermatitis of the face 67
Comparison of clinical and ultrasound scores in patients with hidradenitis suppurativa: results from an Italian ultrasound working group 62
Patient satisfaction with calcipotriol/betamethasone dipropionate cutaneous foam for the treatment of plaque psoriasis: The LION real-life multicenter prospective observational cohort study 50
Prevalence of HPV genital infection in patients with moderate-to-severe psoriasis undergoing systemic treatment with immunosuppressive agents or biologics 48
Italian Guidelines in patch testing - Adapted from the European Society of Contact Dermatitis (ESCD) 47
Correction to: Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study (Archives of Dermatological Research, (2022), 314, 6, (593-603), 10.1007/s00403-021-02243-w) 39
Patch testing of budesonide in Italy: The SIDAPA baseline series experience, 2018–2019 37
Comorbidities and treatment patterns in adult patients with atopic dermatitis: results from a nationwide multicenter study 30
Dimethyl Fumarate's Effectiveness and Safety in Psoriasis: A Real-Life Experience During the COVID-19 Pandemic 30
null 28
Totale 861
Categoria #
all - tutte 5.878
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.878


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20207 0 0 0 0 0 0 0 0 0 0 0 7
2020/202170 2 9 3 1 8 2 1 6 2 8 19 9
2021/202256 0 6 0 0 2 5 0 4 5 3 13 18
2022/2023252 14 26 12 15 18 67 0 17 56 3 21 3
2023/2024146 23 7 10 14 25 41 2 4 2 7 2 9
2024/2025309 20 20 4 4 11 48 68 36 72 16 10 0
Totale 861